Stakeholder capitalism is under attack from both the right and the left

What comes next after the Biogen Alzheimer’s drug approval

Biogen’s Alzheimer’s drug approval could pave the way for major changes across the industry. Read More

There are smarter ways to think about board diversity, and the pressure is on to figure them out

Speaking out against questionable management can pose a risk for tech workers in the minority—but that’s about to change by an act of solidarity. Read More

‘Spiritual opium,’ Facebook, and the metaverse: An alternate reality on the rise

The metaverse may have been hit in China’s escalating tech crackdown, but it lives on in more ways than one. Read More